Transforming Growth Factor-β1 Inhibition of Vascular Smooth Muscle Cell Activation Is Mediated via Smad3
Open Access
- 1 April 2004
- journal article
- Published by Elsevier
- Vol. 279 (16), 16388-16393
- https://doi.org/10.1074/jbc.m309664200
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Essential Role for Smad3 in Regulating MCP-1 Expression and Vascular InflammationCirculation Research, 2004
- Fibrates down-regulate IL-1–stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFκB–C/EBP-β complex formationBlood, 2003
- Inflammation in atherosclerosisNature, 2002
- Transforming Growth Factor-β1 Inhibits Cytokine-mediated Induction of Human Metalloelastase in MacrophagesJournal of Biological Chemistry, 2000
- Expression of the Interleukin-6 Gene Is Constitutive and Not Regulated by Estrogen in Rat Vascular Smooth Muscle Cells in CultureEndocrinology, 1999
- Cross-talk between transcription factors NF-κB and C/EBP in the transcriptional regulation of genesThe International Journal of Biochemistry & Cell Biology, 1997
- Induction by staurosporine of nitric oxide synthase expression in vascular smooth muscle cells: role of NF‐κB, CREB and C/EBPβBritish Journal of Pharmacology, 1997
- Expression of intercellular adhesion molecule-1 on rat vascular smooth muscle cells by pro-inflammatory cytokinesAtherosclerosis, 1993
- Elevation of C-reactive protein in “active” coronary artery diseaseThe American Journal of Cardiology, 1990
- Regulation by angiotensin II of its receptors in resistance blood vesselsNature, 1980